Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4587076
Max Phase: Preclinical
Molecular Formula: C40H61N15O7
Molecular Weight: 864.03
Molecule Type: Unknown
Associated Items:
ID: ALA4587076
Max Phase: Preclinical
Molecular Formula: C40H61N15O7
Molecular Weight: 864.03
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCCC(NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CN)c1ccc2ccccc2c1)C(N)=O
Standard InChI: InChI=1S/C40H61N15O7/c41-15-5-3-10-29(36(59)52-28(35(44)58)12-7-17-48-40(45)46)53-37(60)30(11-4-6-16-42)54-39(62)34(26-14-13-24-8-1-2-9-25(24)18-26)55-38(61)31(19-27-21-47-23-50-27)51-33(57)22-49-32(56)20-43/h1-2,8-9,13-14,18,21,23,28-31,34H,3-7,10-12,15-17,19-20,22,41-43H2,(H2,44,58)(H,47,50)(H,49,56)(H,51,57)(H,52,59)(H,53,60)(H,54,62)(H,55,61)(H4,45,46,48)/t28?,29-,30-,31-,34-/m0/s1
Standard InChI Key: HBYGNPLLBYLDKB-VYCSYZTNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 864.03 | Molecular Weight (Monoisotopic): 863.4878 | AlogP: -3.02 | #Rotatable Bonds: 28 |
Polar Surface Area: 386.33 | Molecular Species: BASE | HBA: 12 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 19 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.88 | CX Basic pKa: 11.53 | CX LogP: -5.44 | CX LogD: -13.23 |
Aromatic Rings: 3 | Heavy Atoms: 62 | QED Weighted: 0.02 | Np Likeness Score: -0.16 |
1. da Silva-Júnior EF, de Araújo-Júnior JX.. (2019) Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses., 27 (18): [PMID:31351847] [10.1016/j.bmc.2019.07.038] |
Source(1):